期刊文献+

西罗莫司和环孢素A对Th17细胞和调节性T淋巴细胞分化影响的比较 被引量:3

Effects of sirolimus vs cyclosporine A on in vitro differentiation of Th17 cells and T regulatory cells
原文传递
导出
摘要 目的比较西罗莫司(SRL)和环孢素A(CsA)对体外诱导CD4^+T淋巴细胞向Th17和调节性T淋巴细胞分化的影响。方法使用抗CD3和抗CD28单克隆抗体(简称抗CD3单抗和抗CD28单抗)刺激CD4^+T淋巴细胞,并在培养体系中分别加入转化生长因子β(TGF-β);TGF-β+白细胞介素6(IL-6);TGF-β+IL-6+SRL;TGF-β+IL-6+CsA。72h后用流式细胞术检测细胞内Foxp3和IL-17的表达水平,观察CD4^+T淋巴细胞的分化情况及SRL和CsA对CD4^+T淋巴细胞体外分化的影响。结果在经抗CD3单抗和抗CD28单抗刺激后,TGF-β可诱导Foxp3^+细胞(调节性T淋巴细胞,Treg)的增殖与分化,而TGF-β+IL6可诱导Th17细胞的增殖与分化。在培养体系中加入SRL和CsA,均可使Th17细胞的增殖与分化减少;SRL可促进Treg的增殖与分化,而CsA抑制Treg的增殖与分化。结论SRL可以促进CD4^+T淋巴细胞向Treg增殖与分化,而抑制Th17细胞的增殖与分化;CsA既抑制Treg的增殖与分化,又抑制Th17细胞的增殖与分化。 Objective To compare the effects of sirolimus (SRL) vs cyclosporine A (CsA) on in vitro differentiation of regulatory T cells and Th17 cells. Methods CD4^+ T cells sorted by FACS were stimulated with anti-CD3 antibody (Ab), anti-CD28Ab and TGF-β, in the presence or absence of IL6. Flow cytometry was used to detect the expression of Foxp3 and IL-17 72 h after stimulation. And SLR or CsA was added to the medium with different concentrations to estimate the effects on differentiation of CD4^+ T cells. Results After being stimulated with anti CD3 Ab and Anti-CD28 Ab, TGF-β mediated generation of T regulatory cells and TGF-β/IL-6 induced generation of Th17 cells. SRL and CsA potently inhibited the TGF-β and IL-6-induced generation of IL-17-producing cells. Intriguingly, SRL promoted, while CsA markedly inhibited, TGF-β mediated generation of T regulatory cells. Conclusion The capacity of SRL to generate immunosuppressive Tregs and to suppress differentiation of pathogenic Th17 cells furthers our understanding of the basis for the therapeutic immunosuppressive effects of SRL in patients with autoimmune diseases and allotransplantation reactions.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2009年第2期100-102,共3页 Chinese Journal of Organ Transplantation
基金 湖北省科技攻关重大项目(2006AA301A06)
关键词 西罗莫司 环孢菌素 T淋巴细胞 细胞分化 Sirolimus Cyclosporine T-lymphocytes Cell differentiation
  • 相关文献

参考文献14

  • 1Veldhoen M, Hocking RJ, Atkins CJ, et al. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity, 2006, 24 (2):179-189.
  • 2Bettelli E,Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 2006,441 (7090) : 235-238.
  • 3Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T (H)17 lineage. Nature, 2006,441 (7090) : 231-234.
  • 4Weaver CT, Harrington LE, Mangan PR, et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity, 2(106,24 (6) : 677-688.
  • 5Afzali B, I.ombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol, 2007,148 (1): 32-46.
  • 6Sakaguchi S, Ono M,Setoguchi R, et al. Foxp3^+ CD25^+ CD4^+ natural regulatory T cells in dominant self tolerance and autoimmune disease. Immunol Rev, 2006,212 ( 1 ) : 8-27.
  • 7Davidson TS, DiPaolo RJ, Andersson J, et al. Cutting edge: IL-2 is essential for TGF-beta medialed induction of Foxp3^+ T regulatory ceils. J Immunol, 2007,178(7) : 4022-4026.
  • 8Abraham RT, Wiederrecht GJ. Immunopharmacology of rapamycin. Annu Rev Immunol, 1996,14 ( 1 ) : 483-510.
  • 9Battaglia M, Stabilini A, Migliavacca B, et al. Rapamycin promotes expansion of functional CD4^+ CD25^+ Foxp3^+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol, 2006,177 (12) : 8338-8347.
  • 10Strauss L, Whiteside TL, Knights A, et al. Selective survival of naturally occurring human CD4^+ CD25^+ Foxp3^+ regulatory T cells cultured with rapamycin. J Immunol, 2007, 178 ( 1 ) : 320- 329.

同被引文献28

  • 1赵峻,张莉蓉,乔海灵.免疫抑制剂硫唑嘌呤的药物不良反应[J].中国误诊学杂志,2006,6(5):839-841. 被引量:25
  • 2肖序仁,徐衍盛,敖建华.不同免疫抑制剂诱导外周血活化T淋巴细胞凋亡的研究[J].中华器官移植杂志,2006,27(11):644-647. 被引量:2
  • 3Sheshgiri R,Gustafsson F,Sheedy J,et al.Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients.J Heart Lung Transplant,2009,28(11):1193-1197.
  • 4Lila N,Amrein C,Guillemain R,et al.Soluble human leukocyte antigen-G:a new strategy for monitoring acute and chronic rejections after heart transplantation.J Heart Lung Transplant,2007,26(4):421-422.
  • 5Shlomchik WD.Graft-versus-host disease.Nat Rev Immunol,2007,7(5):340-352.
  • 6Favier B,LeMsoult J,Rouas-Freiss N,et al.Research on HLA-G:an update.Tissue Antigens,2007,69(3):207-211.
  • 7Puppo F,Contini P,Ghio M,et al.Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CEB+ cells by Fas/Fas-ligand interaction.Scientific World Journal,2002,2:421-423.
  • 8Liang S,Ristieh V,Arase H,et al.Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6STAT3 signaling pathway.Proc Natl Acad Sci U S A,2008,105(24):8357-8362.
  • 9Seo N0 Hayakawa S,Takigawa M,et al.Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4 (+) T-regulatory cells and systemic collapse of antitumour immunity.Immunology,2001,103 (4):449-457.
  • 10Schramm C,Huber S,Protschka M,et al.TGFbeta regulates the CD4^+ CD25^+ T-cell pool and the expression of Foxp3 in vivo.Int Immunol,2004,16(9):1241-1249.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部